mGluR5 promotes the differentiation of rat neural progenitor
cells into cholinergic neurons and activation of extracellular
signal-related protein kinases
Lingyu Zhao
a,b,
*, Qian Jiao
a,
*, Chen Huang
b
, Ni Hou
b
, Xinlin Chen
a
,
Jianshui Zhang
a
, Pengbo Yang
a
, Xi Xu
c
, Tusheng Song
b
and Yong Liu
a
Metabotropic glutamate receptors (mGluRs) regulate
neurogenesis in the mammalian central nervous system
during development and throughout adulthood. However,
the mechanisms remain unknown. The present study
was aimed at investigating the effect of mGluR5 on
the differentiation of rat neural progenitor cells (NPCs)
into neurons as well as the underlying molecular
mechanisms. NPCs were treated with mGluR5 agonist
(RS)-2-chloro-5-hydroxyphenylglycine (CHPG), mGluR5
siRNA, and antagonist 6-methyl-2-(phenylethynyl)
pyridine hydrochloride (MPEP), respectively. Three
different subtypes of neurons (cholinergic, GABAergic,
and dopaminergic neurons) were evaluated, and the
activation of signaling pathways of mitogen-activated
protein kinases was determined. Results showed that
CHPG caused rat NPCs to differentiate into neurons,
whereas mGluR5 siRNA and MPEP inhibited the cell
differentiation. The proportion of cholinergic neurons
increased with CHPG treatment and decreased after
siRNA or MPEP treatment, whereas there were no
significant changes in the proportions of GABAergic
and dopaminergic neurons after treatment.
The phosphorylated ERK1/2 levels increased after CHPG
treatment and decreased after siRNA or MPEP treatment.
In conclusion, our findings showed that mGluR5 caused rat
NPCs to differentiate into cholinergic neurons by activating
ERKs, suggesting that mGluR5 may play a significant role
in the mechanism and treatment of degenerative diseases
such as Alzheimer’s disease. NeuroReport 25:427–434 c
2014 Wolters Kluwer Health | Lippincott Williams & Wilkins.
NeuroReport 2014, 25:427–434
Keywords: central nervous system, dopaminergic neurons, GABAergic
neurons, mitogen-activated protein kinases, neurogenesis
a
Institute of Neurobiology,
b
Department of Genetics and Cell Biology,
Environment and Genes Related to Diseases Key Laboratory of Education
Ministry, Xi’an Jiaotong University College of Medicine and
c
Department of
Anatomy, Xi’an Medical University, Xi’an, People’s Republic of China
Correspondence to Yong Liu, MD, PhD, Institute of Neurobiology, Xi’an Jiaotong
University College of Medicine, Xi’an, Shaanxi 710061, People’s Republic
of China
Tel/fax: + 86 29 8265 5080; e-mail: liuy5599@mail.xjtu.edu.cn
*Lingyu Zhao and Qian Jiao contributed equally to the writing of this article.
Received 29 August 2013 accepted 29 January 2014
Introduction
Neural progenitor cells (NPCs) are multipotent and self-
renewing cells present in the mammalian central nervous
system (CNS) during development and throughout
adulthood. These cells have the potential ability to
differentiate into different neural lineages such as
neurons, astrocytes, and oligodendrocytes [1]. NPCs
can be isolated from embryonic and adult brain, and
expanded as neurospheres in culture in the presence of
basic fibroblast growth factor and epidermal growth
factor [2]. In the last decade, NPC-based therapies have
been repaired successfully for CNS diseases and are
considered very effective for the improvement in
neurologic function in nerve injury, brain ischemia, and
neurodegenerative disorders [3]. Nevertheless, a key
question in cell transplantation and regenerative thera-
pies is how NPCs repair injured neurons. To elucidate the
mechanisms, it is necessary to investigate NPC differ-
entiation and the cellular biology processes.
Glutamate is a major excitatory neurotransmitter in the
CNS that may contribute toward neurogenesis by
activating ionotropic glutamate receptors (iGluRs) and
metabotropic glutamate receptors (mGluRs) [4]. In brain
injuries that involve glutamate excitotoxicity, such as
brain ischemia and epilepsy, glutamate receptor signaling
might regulate the neurogenesis in response to the
injuries. mGluRs, including eight subtypes termed
mGluR1–8, are coupled with G proteins. mGluR5
activates phospholipase C and acts on phosphatidylino-
sitol bisphosphate, causing the increase in two second
messengers: inositol trisphosphate and diacylglycerol [4].
This neurotransmitter was found expressed in zones of
active neurogenesis in the embryonic and postnatal rat
brain, and might specifically support the survival of NPCs
differentiating into neurons [5]. The results of many
studies suggest that mGluR5 might play a very important
role in regulating NPC differentiation in the develop-
ment of CNS or after brain injury [5,6].
Tian et al. [7] reported that the activation of mGluR7
might promote the differentiation of NPCs into neurons
by influencing phosphorylation of RAS/mitogen-activated
protein kinase (MAPK)-signaling pathways. Extracellular
signal-related protein kinase (ERK) is a main member
of the MAPK family and a potential downstream mediator
Cellular, molecular and developmental neuroscience 427
0959-4965 c 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins DOI: 10.1097/WNR.0000000000000134
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.